NARDONE, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 2.048
EU - Europa 1.809
AS - Asia 313
OC - Oceania 4
Totale 4.174
Nazione #
US - Stati Uniti d'America 2.045
GB - Regno Unito 702
IE - Irlanda 420
CN - Cina 206
IT - Italia 166
UA - Ucraina 140
SE - Svezia 137
DE - Germania 71
FR - Francia 69
VN - Vietnam 37
FI - Finlandia 31
TR - Turchia 31
ES - Italia 30
IN - India 26
BE - Belgio 18
IR - Iran 8
IM - Isola di Man 7
RU - Federazione Russa 5
AU - Australia 4
RO - Romania 4
CA - Canada 3
MK - Macedonia 3
AT - Austria 2
BD - Bangladesh 2
HK - Hong Kong 2
PL - Polonia 2
GR - Grecia 1
LT - Lituania 1
TH - Thailandia 1
Totale 4.174
Città #
Southend 654
Dublin 413
Fairfield 315
Chandler 184
Ashburn 152
Woodbridge 144
Ann Arbor 136
Wilmington 130
Jacksonville 117
Seattle 112
Houston 100
Menlo Park 99
Cambridge 93
Siena 74
Beijing 55
New York 54
Princeton 46
Dearborn 37
Dong Ket 37
Fremont 30
Izmir 30
Málaga 30
Nanjing 29
Shanghai 22
Helsinki 20
Brussels 18
Boardman 17
San Mateo 15
Florence 14
San Diego 13
Shenyang 11
Tianjin 11
Nanchang 9
Douglas 7
Falls Church 7
Hebei 7
Jiaxing 7
Kunming 7
Changsha 6
Zanjan 6
Zhengzhou 6
Fort Worth 5
Massa 5
Phoenix 5
Sacramento 5
Fuzhou 4
Hangzhou 4
Jinan 4
Ningbo 4
Reggio Calabria 4
Timisoara 4
Guangzhou 3
Henderson 3
Hounslow 3
Lancaster 3
Milan 3
Mumbai 3
Redwood City 3
San Vitaliano 3
Skopje 3
Bari 2
Bhopal 2
Delhi 2
Dhaka 2
Duncan 2
Falkenstein 2
Hong Kong 2
Islington 2
Kilburn 2
Lanzhou 2
London 2
Priocca 2
Rome 2
Sezze 2
Taizhou 2
Tehran 2
Turin 2
Vienna 2
Vijayawada 2
Wuhan 2
Adelaide 1
Aigaleo 1
Airdrie 1
Asciano 1
Bangalore 1
Borghetto Lodigiano 1
Brainerd 1
Buffalo 1
Calenzano 1
Campi Bisenzio 1
Canberra 1
Carraia 1
Caserta 1
Cessaniti 1
Changchun 1
Chaoyang 1
Chiswick 1
Chongqing 1
College Station 1
Colorado Springs 1
Totale 3.405
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 230
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 207
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 197
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 191
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 179
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 171
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 151
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 150
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 145
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 144
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report 144
Is there a potential role for EGFR expression to lead margin reduction in glioblastoma? 142
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 141
null 139
Texture analysis of parotid gland as a predictive factor of radiation induced xerostomia: A subset analysis 138
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk. 136
null 130
null 126
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 125
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 124
null 117
null 116
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 115
null 82
Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis 78
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 57
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 48
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 45
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 43
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 39
In Regard to Kubicek et al. 38
Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer) 32
CONFIRM trial: what is the real efficacy of second-line immunotherapy in mesothelioma? 32
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect? 31
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 24
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 22
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 14
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma 8
Totale 4.290
Categoria #
all - tutte 11.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.489


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019291 0 0 0 0 0 0 0 0 0 0 160 131
2019/2020939 97 27 62 111 61 95 93 112 100 95 37 49
2020/2021753 35 81 18 67 56 94 39 99 59 94 27 84
2021/2022444 29 56 35 17 31 26 29 27 30 44 46 74
2022/2023654 31 62 92 77 66 123 20 56 62 37 15 13
2023/2024601 16 11 60 31 20 174 271 3 6 8 1 0
Totale 4.290